Acute autoimmune hemolytic anemia due to anti-En autoantibody successfully treated with rituximab.

Autoimmune hemolytic anemia (AIHA) due to anti-En has been previously reported in association with massive intravascular hemolysis, disseminated intravascular coagulation, and fatal outcomes. Here we report a case of successfully treated AIHA due to anti-En .